Literature DB >> 7893442

The role of initial AIDS-defining illness in survival following AIDS.

K Luo1, M Law, J M Kaldor, A M McDonald, D A Cooper.   

Abstract

OBJECTIVE: To examine the role of initial AIDS-defining illness in survival following AIDS and survival trends over time.
DESIGN: States and Territory Health Departments notified new diagnoses of AIDS to the National AIDS Registry. Information on vital status and date of last medical contact was sought annually.
METHODS: Survival was calculated for all adult and adolescent AIDS cases (n = 3204) in Australia diagnosed until 1 November 1991 and reported to the National AIDS Registry by 31 March 1994. The Cox regression method was used to identify independent predictors for survival.
RESULTS: Age < 50 years, a CD4+ cell count > or = 100 x 10(6)/l and an initial diagnosis of Kaposi's sarcoma were independently associated with longer survival (P < 0.05). Acquisition of HIV through blood transfusion and the AIDS-defining illness non-Hodgkin's lymphoma were significantly associated with shorter survival. Survival improved substantially from 1986 to 1987, but did not improve further thereafter. A further study of initial AIDS-defining illnesses in a subgroup of individuals, i.e., men aged < 50 years at diagnosis who acquired HIV infection through homosexual or bisexual contact and diagnosed after 1987, showed that Kaposi's sarcoma, Pneumocystis carinii pneumonia, oesophageal candidiasis and herpes simplex virus as initial AIDS-defining illnesses had a relatively better prognosis than other single illnesses. Furthermore, patients with multiple illnesses did not have a worse prognosis than patients with a single illness, provided all illnesses were those with a better prognosis.
CONCLUSIONS: Initial AIDS-defining illness, as well as age at diagnosis, year of diagnosis, HIV exposure and CD4+ cell count at diagnosis, plays an important role in survival following AIDS in Australia.

Entities:  

Mesh:

Year:  1995        PMID: 7893442     DOI: 10.1097/00002030-199501000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

Review 1.  Clinical dilemmas in palliative care for HIV infection.

Authors:  S C Matheny
Journal:  J R Soc Med       Date:  2001-09       Impact factor: 5.344

2.  Prognostic factors correlated with survival in AIDS patients.

Authors:  S Casari; A Donisi; G Paraninfo; D Tomasoni; L Palvarini; P Nasta; A Bergamasco; G P Cadeo; G Carosi
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

3.  AIDS survival and progression in black Africans living in south London, 1986-1994.

Authors:  N Low; K Paine; R Clark; M Mahalingam; A L Pozniak
Journal:  Genitourin Med       Date:  1996-02

4.  Caring for patients with HIV and AIDS in middle income countries.

Authors:  E Van Praag; J H Perriens
Journal:  BMJ       Date:  1996-08-24

5.  Impaired Neurocognitive Performance and Mortality in HIV: Assessing the Prognostic Value of the HIV-Dementia Scale.

Authors:  Nikhil Banerjee; Roger C McIntosh; Gail Ironson
Journal:  AIDS Behav       Date:  2019-12

6.  Survival by AIDS defining condition in rural Uganda.

Authors:  D Morgan; S S Malamba; J Orem; B Mayanja; M Okongo; J A Whitworth
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

7.  HIV-related non-Hodgkin's lymphoma in Calgary.

Authors:  P L Beck; M J Gill; W B Blahey; L R Sutherland
Journal:  Can J Infect Dis       Date:  1996-03

8.  Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.

Authors:  Amanda Mocroft; Jonathan A C Sterne; Matthias Egger; Margaret May; Sophie Grabar; Hansjakob Furrer; Caroline Sabin; Gerd Fatkenheuer; Amy Justice; Peter Reiss; Antonella d'Arminio Monforte; John Gill; Robert Hogg; Fabrice Bonnet; Mari Kitahata; Schlomo Staszewski; Jordi Casabona; Ross Harris; Michael Saag
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

9.  Survival differences in Austrian patients with the acquired immunodeficiency syndrome.

Authors:  R Zangerle; G Reibnegger; J P Klein
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

10.  Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study.

Authors:  Siavash Jafari; Keith Chan; Kewan Aboulhosn; Benita Yip; Viviane D Lima; Robert S Hogg; Julio Montaner; David M Moore
Journal:  AIDS Res Ther       Date:  2011-09-05       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.